![]() ![]() You can get professional event planning help from the Ann Arbor Area Convention and Visitors Bureau. Lineage-defined Metabolism of Normal Mammary Cells and Origins of Cancer Metabolic HeterogeneityĪACR DISTINGUISHED LECTURESHIP IN BREAST CANCER RESEARCH, supported by Aflac Inc.A list of locations to have a meeting, from 12 people to 109,901 people. ![]() Oncogene signal transduction and antiestrogen resistance Kent Osborne HER2 and ER Crosstalk: Signaling Mechanisms and Clinical Implications Symposium HER2 Low: A Separate Entity? Special Session - Hall 3Ĭ. Leveraging Preclinical Models for Translational Breast Cancer Research SPOTLIGHT POSTER DISCUSSION SESSION #6 Special Populations: Male Breast Cancer/Geriatrics - Stars at Night Ballroom 1&2 SPOTLIGHT POSTER DISCUSSION SESSION #5 Advances in TNBC Biology - Stars at Night Ballroom 3&4 SPOTLIGHT POSTER DISCUSSION SESSION #4 Single Cell Approaches for Translational Research and Biomarker Discovery - Hemisfair Ballroom 1&2 Medical Crossfire®: Clinical Decision Making Under New Paradigms for HR+/HER2-Breast Cancer presented by Physicians' Education Resource, LLC OPEN SATELLITE EVENTS - Marriott RivercenterĬlarifying the Complexities and Augmenting the Options in the Treatment of HR+/HER2- Breast Cancer: How to Build Better Skills to Make the Most of Existing and Emerging Therapies for the Benefit of Patients With HR+/HER2- MBC and EBC presented by PVI, PeerView Institute for Medical EducationĮxpanding the Spectrum of HER2-Positivity for Precision Breast Cancer Care:Clinical Implications of HER2-Low Status presented by Clinical Care Options,LLC SPOTLIGHT POSTER DISCUSSION SESSION #3 New Radiation Techniques - Stars at Night Ballroom 3&4 SPOTLIGHT POSTER DISCUSSION SESSION #2 Tumor Immunology and Novel Immune Therapy Strategies - Stars at Night Ballroom 1&2 SPOTLIGHT POSTER DISCUSSION SESSION #1 Racial Outcomes and Disparities - Hemisfair Ballroom 1&2 University of North Carolina at Chapel Hill University of Pennsylvania Abramson Cancer Center ![]() Overcoming the Big Obstacles to Find Solutions for Breast Cancer SPECIAL SESSION #1 - Stars at Night Ballroom 1&2 Predictive Value of Treatment Response and Residual Disease After Neoadjuvant Therapy Mechanisms of sensitivity and resistance to HRD targeting agents in breast cancer - PARPi and beyondĪTR inhibitors and PARP1 selective PARP inhibitorsĮDUCATIONAL SESSION BLOCK #1D - Stars at Night Ballroom 1&2 New Agents Targeting HRD in Breast Cancer How to reconcile novel reconstructive techniques with the need to radiateĮDUCATIONAL SESSION BLOCK #1C - Hemisfair Ballroom 3 GRASP - Guiding Researchers & Advocates to Scientific PartnershipsĮDUCATIONAL SESSION BLOCK #1B - Hemisfair Ballroom 1&2Ĭontralateral mastectomy in patients with germline mutations University College London, Cancer InstituteĮDUCATIONAL SESSION BLOCK #1A - Stars at Night Ballroom 3&4 Therapy-induced senescence: Friend or foe?Ĭlinical implications of tumor heterogeneity single cell genomics ![]() Statistical considerations for precision medicineīringing trials to all patients: A patient's perspectiveīasic Science Workshop - Stars at Night Ballroom 3&4 How to measure and improve drug adherence in clinical trials Use of the postneoadjuvant setting to accelerate drug development Tuesday, December 6, 2022 All times are CENTRAL TimeĬlinical Research Workshop - Stars at Night Ballroom 1&2 TO VIEW THE FULL SCHEDULE SEE THE DAILY SCHEDULE AND SESSIONS LIST ![]()
0 Comments
Leave a Reply. |
Details
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |